Biotechnology Analyst Robert Leboyer Joins Leerink Swann Equity Research Team.Business Editors BOSTON--(BUSINESS WIRE)--March 3, 2000 Leerink Swann & Co., Inc., a Boston-based investment banking firm whose equity research unit focuses on biotechnology, pharmaceuticals and medical devices, has announced the appointment of Robert M. LeBoyer as Vice President, biotechnology research. Jeffrey A. Leerink, Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Leerink Swann & Company, said, "We are pleased to have Robert LeBoyer join our research team. He is well known and respected within the biotech community. Robert has built an excellent reputation for providing in-depth analysis on biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. and their respective technology platforms to institutional clients over the past decade. Robert's experience in analyzing the full spectrum of biotechnology companies will be of value to our entire research team and to our clients." Mr. LeBoyer joins the Leerink Swann research team from KPMG KPMG Klynveld Peat Marwick Goerdeler (accounting firm) KPMG Kaiser Permanente Medical Group KPMG Keiner Prüft Mehr Genau (German) KPMG Kommen Prüfen Meckern Gehen Peat Marwick, Princeton, New Jersey
Princeton, New Jersey is located in Mercer County, New Jersey, United States. Princeton University has been sited in the town since 1756. , where he was a Senior Director of Corporate Finance, concentrating on early-stage biotechnology companies. From 1994 through 1998, Mr. LeBoyer was the Senior Biotechnology Analyst at Brown Brothers Harriman & Co., Inc., New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of , where he initiated extensive new coverage of the biotechnology industry. His coverage included Amgen, Biogen, Genentech, and Chiron, and many other promising biotech firms. Mr. LeBoyer began his career in research at Prudential Securities, New York, where he was an Assistant Vice President, Equity Research from 1992 to 1994. "This is an exciting time for the Biotechnology industry," said Robert LeBoyer. "The Leerink Swann/MEDACorp network and Physicians Conference Series are unique resources that give excellent access to doctors in clinical practice." A graduate of Tulane University History Founding/early history The University dates from 1834 as the Medical College of Louisiana.<ref name="facts" /> With the addition of a law department, it became The University of Louisiana , where he earned his Bachelor's degree in Economics, Mr. LeBoyer holds an MBA MBA abbr. Master of Business Administration Noun 1. MBA - a master's degree in business Master in Business, Master in Business Administration in Finance and Operations from Columbia University. Leerink Swann & Company is a Boston-based investment banking firm and asset management firm with an expert equity research group specializing in biotechnology, pharmaceuticals and medical devices. Leerink Swann, through its affiliate MEDACorp, has a unique network of more than 400 biotechnology professionals whose assessments augment the analysis of the firm's research. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion